Back
Chevron Corp. Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison
Sell
37
CVX
Chevron Corp.
Last Price:
$159.38
Seasonality Move:
3.48%
Sell
38
CRNX
Crinetics Pharmaceuticals, Inc.
Last Price:
$53.22
Seasonality Move:
-13.28%
Sell
37
Chevron Corp. (CVX)
is a Sell
Is Chevron Corp. a Buy, Sell or Hold?
-
The current Chevron Corp. [CVX] share price is $155.20. The Score for CVX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
CVX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Crinetics Pharmaceuticals, Inc. (CRNX)
is a Sell
Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.34. The Score for CRNX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CVX Stock Price Chart
What is Chevron Corp.'s stock price today?
-
The Chevron Corp. share price today is $155.20Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVX is experiencing selling pressure, which indicates risk of future bearish movement.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals, Inc.'s stock price today?
-
The Crinetics Pharmaceuticals, Inc. share price today is $53.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CVX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.44 | Buy |
| Relative Strength Index (14 RSI): | 54.75 | Buy |
| Chaikin Money Flow: | -10921860 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (147.85 - 154.79) | Buy |
| Bollinger Bands (100): | (150.64 - 157.66) | Buy |
CRNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.96 | Buy |
| Relative Strength Index (14 RSI): | 66.03 | Buy |
| Chaikin Money Flow: | 3428689 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.13 - 49.63) | Buy |
| Bollinger Bands (100): | (35.09 - 47.19) | Buy |
CVX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 154.65 | Buy |
| 20-day SMA: | 151.51 | Buy |
| 50-day SMA: | 152.34 | Buy |
| 200-day SMA: | 150.15 | Buy |
| 8-day EMA: | 155.1 | Buy |
| 20-day EMA: | 152.93 | Buy |
| 50-day EMA: | 152.51 | Buy |
| 200-day EMA: | 152.08 | Buy |
CRNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.2 | Buy |
| 20-day SMA: | 48.28 | Buy |
| 50-day SMA: | 45.42 | Buy |
| 200-day SMA: | 36 | Buy |
| 8-day EMA: | 48.68 | Buy |
| 20-day EMA: | 47.84 | Buy |
| 50-day EMA: | 45.56 | Buy |
| 200-day EMA: | 40.15 | Buy |
Chevron Corp. Earnings Growth & CVX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $2.37 per share.
Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.55 per share.
Chevron Corp. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Crinetics Pharmaceuticals, Inc. Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||